Clinical Trial Update: Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dalteparin in combination with radiation therapy for newly diagnosed supratentorial glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Glioblastoma Multiforme

Drugs mentioned

• Dalteparin (dalteparin)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED